INTELLIA THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
INTELLIA THERAPEUTICS, INC. (NTLA) had Operating Lease Right-of-Use Assets of $85.95 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $85.95M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $97.54M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $105.95M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $117.88M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $85.95M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $97.54M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $105.95M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $117.88M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $129.04M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $137.98M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $219.29M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $100.33M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $105.41M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $110.42M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $115.38M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $118.78M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $123.55M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $128.26M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $133.08M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $101.29M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $73.78M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $76.47M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $79.14M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $81.79M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.40M 10-K · filed 2022-02-24 | $77.07M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $77.91M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $39.11M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $22.21M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $23.47M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $24.92M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $19.14M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $20.66M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $20.92M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $21.01M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |